A carregar...

Randomized Phase III Trial of Piroxicam in Combination with Mitoxantrone or Carboplatin for First‐Line Treatment of Urogenital Tract Transitional Cell Carcinoma in Dogs

BACKGROUND: Reported response rates of transitional cell carcinoma (TCC) in dogs to piroxicam in combination with either mitoxantrone or carboplatin are similar; however, it is unknown whether either drug might provide superior duration of response. HYPOTHESIS/OBJECTIVES: To determine if the progres...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Vet Intern Med
Main Authors: Allstadt, S.D., Rodriguez, C.O., Boostrom, B., Rebhun, R.B., Skorupski, K.A.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4858101/
https://ncbi.nlm.nih.gov/pubmed/25619518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvim.12533
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!